丁建文，黄亮. 胱天蛋白酶募集域蛋白9在非感染性炎症疾病中的研究进展[J]. 中国急救医学, 2018, 38(8): 736-740.
Ding Jian-wen, Huang Liang. Update of caspase recruitment domain protein 9 in non-infectious inflammatory diseases. Chinese Journal of Critical Care Medicine, 2018, 38(8): 736-740.
［1］Bertin J, Guo Y, Wang L, et al. CARD9 is a novel caspase recruitment domain-containing protein that interacts with BCL10/CLAP and activates NF-kappa B［J］. J Biol Chem, 2000, 275(52): 41 082-41 086.
［2］Hsu YM, Zhang Y, You Y, et al. The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens［J］. Nat Immunol, 2007, 8(2): 198-205.
［3］Sancho D, Reis e Sousa C. Signaling by myeloid C-type lectin receptors in immunity and homeostasis［J］. Annu Rev Immunol, 2012, 30: 491-529.
［4］Gross O, Gewies A, Finger K, et al. Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity［J］. Nature,2006, 442(7103): 651-656.
［5］Jia XM, Tang B, Zhu LL, et al. CARD9 mediates Dectin-1-induced ERK activation by linking Ras-GRF1 to H-Ras for antifungal immunity［J］. J Exp Med, 2014, 211(11): 2307-2321.
［6］Whibley N, Jaycox JR, Reid D, et al. Delinking CARD9 and IL-17: CARD9 Protects against Candida tropicalis Infection through a TNF-α–Dependent, IL-17–Independent Mechanism［J］. J Immunol, 2015, 195(8): 3781-3792.
［7］Zhao XQ, Zhu LL, Chang Q, et al. C-type lectin receptor dectin-3 mediates trehalose 6,6′-dimycolate (TDM)-induced Mincle expression through CARD9/Bcl 10/MALT1-dependent nuclear factor (NF)-κB activation［J］. J Biol Chem, 2014, 289(43): 30 052-30 062.
［8］Parkhouse R, Boyle JP, Mayle S, et al. Interaction between NOD2 and CARD9 involves the NOD2 NACHT and the linker region between the NOD2 CARDs and NACHT domain［J］. FEBS Lett, 2014, 588(17): 2830-2836.
［9］Loo YM, Gale M Jr. Immune signaling by RIG-I-like receptors［J］. Immunity, 2011, 34(5): 680-692.
［10］Poeck H, Bscheider M, Gross O, et al. Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta production［J］. Nat Immunol, 2010, 11(1): 63-69.
［11］Abdullah Z, Schlee M, Roth S, et al. RIG‐I detects infection with live Listeria by sensing secreted bacterial nucleic acids［J］. Embo J, 2014, 31(21): 4153-4164.
［12］Palmer JN, Hartogensis WE, Patten M, et al. Interleukin-1 beta induces cardiac myocyte growth but inhibits cardiac fibroblast proliferation in culture［J］. J Clin Invest, 1995, 95(6): 2555-2564.
［13］Van Tassell BW, Arena RA, Toldo S, et al. Enhanced Interleukin-1 Activity Contributes to Exercise Intolerance in Patients with Systolic Heart Failure［J］. PloS One, 2012, 7(3): e33 438.
［14］Bozkurt B, Kribbs SB, Clubb FJ Jr, et al. Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats［J］. Circulation, 1998, 97(14): 1382-1391.
［15］Coles B, Fielding CA, Rose-John S, et al. Classic interleukin-6 receptor signaling and interleukin-6 trans-signaling differentially control angiotensin II-dependent hypertension, cardiac signal transducer and activator of transcription-3 activation, and vascular hypertrophy in vivo［J］. Am J Pathol, 2007, 171(1): 315-325.
［16］Van Tassell BW, Arena R, Biondi-Zoccai G, et al. Effects of interleukin-1 blockade with anakinra on aerobic exercise capacity in patients with heart failure and preserved ejection fraction (from the D-HART pilot study)［J］. Am J Cardiol, 2014, 113(2): 321-327.
［17］Cao L, Qin X, Peterson MR, et al. CARD9 knockout ameliorates myocardial dysfunction associated with high fat diet-induced obesity［J］. J Mol Cell Cardiol, 2016, 92: 185-195.
［18］Ren J, Yang M, Qi G, et al. Proinflammatory Protein CARD9 Is Essential for Infiltration of Monocytic Fibroblast Precursors and Cardiac Fibrosis Caused by Angiotensin II Infusion［J］. Am J Hypertens, 2011, 24(6): 701-707.
［19］Johansson ME, Zhang XY, Edfeldt K, et al. Innate immune receptor NOD2 promotes vascular inflammation and formation of lipid-rich necrotic cores in hypercholesterolemic mice［J］. Eur J Immunol, 2014, 44(10): 3081-3092.
［20］Liu Y, Wang Y, Shi H, et al. CARD9 mediates necrotic smooth muscle cell-induced inflammation in macrophages contributing to neointima formation of vein grafts［J］. Cardiovasc Res, 2015, 108(1): 148-158.
［21］Saeki K, Kanai T, Nakano M, et al. CCL2-induced migration and SOCS3-mediated activation of macrophages are involved in cerulein-induced pancreatitis in mice［J］. Gastroenterology, 2012, 142(4): 1010-1020.
［22］Bishu S, Hernández-Santos N, Simpson-Abelson MR, et al. The adaptor CARD9 is required for adaptive but not innate immunity to oral mucosal Candida albicans infections［J］. Infection Immunity, 2014, 82(3): 1173-1180.
［23］Yang ZW, Weng CZ, Wang J, et al. The role of Card9 overexpression in peripheral blood mononuclear cells from patients with aseptic acute pancreatitis［J］. J Cell Mol Med， 2016, 20(3): 441-449.
［24］Yang ZW, Meng XX, Zhang C, et al. CARD9 gene silencing with siRNA protects rats against severe acute pancreatitis: CARD9-dependent NF-κB and p38 MAPKs pathway［J］. J Cell Mol Med， 2017, 21(6): 1085-1093.
［25］Zhernakova A, Festen EM, Franke L, et al. Genetic Analysis of Innate Immunity in Crohn′s Disease and Ulcerative Colitis Identifies〖JP〗 Two Susceptibility Loci Harboring CARD9 and IL 18 RAP［J］. Am J Hum Genet， 2008, 82(5): 1202-1210.
［26］Rivas MA, Beaudoin M, Gardet A, et al. Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease［J］. Nat Genet， 2011, 43(11): 1066-1073.
［27］Cooke J, Zhang H, Greger L, et al. Mucosal genome-wide methylation changes in inflammatory bowel disease［J］. Inflamm Bowel Dis， 2012, 18(11): 2128-2137.
［28］Wang Z, Fan R, Wang L, et al. Genetic association between CARD9 variants and inflammatory bowel disease was not replicated in a Chinese Han population［J］. Int J Clin Exp Pathol， 2015, 8(10): 13 465-13 470.
［29］Sokol H, Conway KL, Zhang M, et al. Card9 mediates intestinal epithelial cell restitution, T-helper 17 responses, and control of bacterial infection in mice［J］. Gastroenterology， 2013, 145(3): 591-601.
［30］Leshchiner ES, Rush JS, Durney MA, et al. Small-molecule inhibitors directly target CARD9 and mimic its protective variant in inflammatory bowel disease［J］. Proc Natl Acad Sci USA， 2017, 114(43): 11 392-11 397.
［31］Lamas B, Richard ML, Leducq V, et al. CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands［J］. Nat Med， 2016, 22(6): 598-605.
［32］Janse M, Lamberts LE, Franke L, et al. Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis〖JP〗 and indicate a role for IL2, REL and CARD9 Contact Information: Rinse K . Weersma, MD, PhD, Organization for Scientific Research (NWO ) to RKW . SR is su［J］. Hepatology， 2011, 53(6): 1977-1985.
［33］Pointon JJ, Harvey D, Karaderi T, et al. Elucidating the chromosome 9 association with AS; CARD9 is a candidate gene［J］. Genes Immun， 2010, 11(6): 490-496.
［34］Arya R, Del Rincon I, Farook VS, et al. Genetic Variants Influencing Joint Damage in Mexican Americans and European Americans With Rheumatoid Arthritis［J］. Genet Epidemiol， 2016, 39(8): 678-688.
［35］Ludwig RJ. Signalling and targeted therapy of inflammatory cells in epidermolysis bullosa acquisita［J］. Exp Dermatol， 2017, 26(12): 1179-1186.
［36］Lee EJ, Brown BR, Vance EE, et al. Mincle Activation and the Syk/Card9 Signaling Axis Are Central to the Development of Autoimmune Disease of the Eye［J］. J Immunol， 2016, 196(7): 3148-3158.
［37］He Y, Xu L, Li B, et al. Macrophage-Inducible C-Type Lectin/Spleen Tyrosine Kinase Signaling Pathway Contributes to Neuroinflammation After Subarachnoid Hemorrhage in Rats［J］. Stroke， 2015, 46(8): 2277-2286.
